Cargando…
Expression of Osteoprotegerin in Placenta and Its Association with Preeclampsia
BACKGROUND: Osteoprotegerin (OPG), a key regulatory factor in bone metabolism, was documented also a potential pro-angiogenic factor, which acts an important role in protecting vascular endothelial cells. Since preeclampsia has gradually been employed to be vascular diseases, we speculated that OPG...
Autores principales: | Shen, Pei, Gong, Yunhui, Wang, Tao, Chen, Yueyue, Jia, Jin, Ni, Shanshan, Zhou, Bin, Song, Yapin, Zhang, Lin, Zhou, Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431377/ https://www.ncbi.nlm.nih.gov/pubmed/22952959 http://dx.doi.org/10.1371/journal.pone.0044340 |
Ejemplares similares
-
Inconformity of CXCL3 Plasma Level and Placenta Expression in Preeclampsia and Its Effect on Trophoblast Viability and Invasion
por: Gui, Shunping, et al.
Publicado: (2014) -
Nitrous oxide synthase expression in placenta of preeclampsia.
por: Lee, C. N., et al.
Publicado: (1997) -
Expression of osteoprotegerin and osteoprotegerin ligand in giant cell tumor of bone and its clinical significance
por: YU, XIUCHUN, et al.
Publicado: (2013) -
Placenta-Derived Osteoprotegerin Is Required for Glucose Homeostasis in Gestational Diabetes Mellitus
por: Huang, Binbin, et al.
Publicado: (2020) -
Distinct expression profiles of peptides in placentae from preeclampsia and normal pregnancies
por: Huang, Jin, et al.
Publicado: (2020)